Background: The TAPER Study aims to explore what matters most to women and healthcare professionals (HCPs) when women consider stopping or restarting hormone replacement therapy (HRT). There is limited evidence to help women and their HCPs decide when and how to stop HRT. Stopping HRT often leads to the recurrence of menopausal symptoms which can negatively affect quality of life. Some women choose to restart HRT which can lead to a stop-restart cycle. This cycle may adversely affect women and increase healthcare use and costs. Methods: An exploratory qualitative study was conducted using semi-structured interviews. Twenty-six women aged 50-67 years were recruited through GP surgeries serving diverse populations and targeted social media adverts shared by community organisations. All interviews were all conducted remotely. Participants identified as Asian (n=4), Black (n=1) Mixed ethnicity (n=1) or white (n=20). Following informed consent, interviews were audio-recorded, transcribed and anonymised, and uploaded to NVivo 14 to support data management and analysis. Transcripts were analysed using codebook thematic analysis, using an iterative deductive-inductive approach in which the discussion guide was used to create the initial deductive coding template. Findings: Women made decisions to start, continue, stop, and/or restart HRT at different points, based on wider influences and assessments of their personal risk. These influences and risk assessments frequently intersected and included fear of, or actual, symptom recurrence; family experiences of menopause; perceived breast cancer risk; time spent using HRT; and considerations about whether they were post-menopausal. Women described uncertainty about the impact of stopping HRT and wanted more information about the likelihood and management of symptom recurrence following discontinuation. Interpretation: Women’s decision-making around HRT discontinuation and restarting was influenced by multiple, intersecting factors. Individualised support and clear information were needed to enable informed decision making and support women choosing to discontinue HRT.